Funding Tracker/Skribe Medical
Previously raised pre-seed · Wearables & Remote Monitoring
Skribe Medical: $1.6M previously raised pre-seed
Disclosed November 11, 2026
The round
The SignalSkribe Medical disclosed a previously raised $1.65 million pre-seed round in its November 11, 2026 release. SeaX Ventures led the round. The original financing date is not supplied; November 11 is the disclosure date, not a new round announcement.
What Skribe Medical does
Wearable cardiac assessment for cardio-oncology research.
Skribe Medical announced its selection for the FDA READI-Home innovation program in a November 11, 2026 release. It is developing wearable cardiac assessment for people receiving cancer treatment. Program participation is not FDA marketing authorization. The release discloses a previously raised $1.65 million pre-seed round led by SeaX Ventures with GoAhead Ventures and Marin Sonoma Impact Ventures. November 11 is the disclosure date, not a verified date of a new financing close. Ryan Neely, PhD is co-founder and CEO.
Full Skribe Medical profile- Company
- Skribe Medical
- Amount
- $1.6M
- Stage
- Previously raised pre-seed
- Disclosed
- November 11, 2026
- Led by
- SeaX Ventures
- Other investors
- GoAhead Ventures, Marin Sonoma Impact Ventures
- Vertical
- Wearables & Remote Monitoring